These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16534464)

  • 1. Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?
    Fleiner F; Fritsche L; Glander P; Neumayer HH; Budde K
    Transplantation; 2006 Mar; 81(5):655-9. PubMed ID: 16534464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in reporting of acute rejections between American and European publications of large immunosuppressive trials impair comparability of study results.
    Fleiner F; Budde K; Dragun D; Hartmann M; Neumayer HH; Fritsche L
    Transplant Proc; 2005 Jun; 37(5):2048-50. PubMed ID: 15964335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why rejections are not biopsy proven: frequency and reasons.
    Fleiner F; Glander P; Fritsche L; Neumayer HH; Budde K
    Transplant Proc; 2010 Dec; 42(10):4509-12. PubMed ID: 21168726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated acute cellular rejection of the liver after simultaneous liver and kidney transplantation: a case report.
    Nah YW; Nam CW; Suh JH; Cha HJ; Kim GY; Park SJ; Oh Y; Cho HR
    Transplant Proc; 2008 Oct; 40(8):2832-4. PubMed ID: 18929875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
    Krämer BK; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Ortuño J; Sester U; Kunzendorf U; Dietl KH; Bonomini V; Rigotti P; Ronco C; Tabernero JM; Rivero M; Banas B; Mühlbacher F; Arias M; Montagnino G;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
    Troncoso P; Ortiz AM; Jara A; Vilches S
    Transplant Proc; 2009; 41(1):127-30. PubMed ID: 19249495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions].
    Snanoudj R; Martinez F; Sberro Soussan R; Thervet E; Legendre C
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S192-9. PubMed ID: 19000886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
    Pietruck F; Budde K; Salvadori M; Sollinger H; Bourbigot B; Gentil MA; Oppenheimer F
    Clin Transplant; 2007; 21(1):117-25. PubMed ID: 17302600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of four DNA polymorphisms with acute rejection after kidney transplantation.
    Grinyó J; Vanrenterghem Y; Nashan B; Vincenti F; Ekberg H; Lindpaintner K; Rashford M; Nasmyth-Miller C; Voulgari A; Spleiss O; Truman M; Essioux L
    Transpl Int; 2008 Sep; 21(9):879-91. PubMed ID: 18444945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN; Mela M; Quaglia A; Triantos CK; Thalheimer U; Leandro G; Pesci A; Raimondo ML; Dhillon AP; Rolles K; Davidson BR; Patch DW; Burroughs AK
    Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
    Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
    Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines.
    Dmitrienko S; Balshaw R; Machnicki G; Shapiro RJ; Keown PA
    Transplantation; 2009 Feb; 87(4):570-7. PubMed ID: 19307796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.